Previous Article | Next Article 
Journal of Clinical Microbiology, July 2007, p. 2351-2352, Vol. 45, No. 7
0095-1137/07/$08.00+0 doi:10.1128/JCM.00908-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Analysis of Phenotypic Variants of the Serogroup C ET-15 Clone of Neisseria meningitidis by Pulsed-Field Gel Electrophoresis

LETTER
In Canada, two waves of hyperendemic meningococcal diseases
were documented in the last 20 years. Both were due to a unique
clone of serogroup C
Neisseria meningitidis designated by multilocus
enzyme electrophoresis as ET-15 (
1). When this clone first appeared,
it was characterized by the antigenic formula C:2a:P1.5,2 (
1).
In 2001, antigenic variants of this ET-15 clone characterized
as C:2a:P1.7,1 (
7) or C:2a:P1.5 (
4) emerged to cause outbreaks
(
8). In this study, we examined whether pulsed-field gel electrophoresis
(PFGE) can be used as a discriminatory tool to differentiate
between the antigenic variants C:2a:P1.7,1, C:2a:P1.5, and C:2a:P1.5,2
of the ET-15 clone of
N. meningitidis.
Eleven serogroup C ET-15 N. meningitidis isolates from invasive meningococcal disease cases were selected for this study. Ten of the 11 serogroup C isolates were identified as serotype 2a. DNA sequencing of the porB gene of the nontypeable isolate identified it as a serotype 2a mutant containing a previously described mutational hot spot (2). There were four different combinations of serosubtype antigens observed for these 11 isolates: 5 with the P1.5 antigen, 3 with the P1.7,1 antigens, 2 with the P1.5,2 antigens, and 1 with the P1.2 antigen. The porA genes of these strains were sequenced, and their PorA variable regions (VRs) are summarized in Fig. 1.
Multilocus sequence typing was performed according to the established
method by Maiden et al. (
3) and isolates were assigned sequence
types according to the
Neisseria Multi Locus Sequence Typing
website (
http://pubmlst.org/neisseria/). An additional region
in the
fumC gene was amplified to determine the presence of
a G-to-A point mutation at position 360, characteristic of ET-15
strains (
11). All 11 isolates contained this particular point
mutation and were therefore classified as ET-15 strains.
PFGE analysis of the 11 isolates that represented the three antigenic variants, C:2a:P1.5,2, C:2a:P1.7,1, and C:2a:P1.5, was performed as described by Tyler and Tsang (9). Restriction enzyme digestion of genomic DNA with NheI (data not shown) and SpeI indicated that serogroup C ET-15 variants had overall similarity and were difficult to distinguish based on the banding patterns they exhibited (Fig. 1). Using SpeI, PFGE pattern I was unique to isolates with the serosubtype P1.5 antigen. However, pattern II was common to all three ET-15 antigenic variants, while pattern III was common to C:2a:P1.5,2 and C:2a:P1.7,1 isolates, and pattern IV was common to C:2a:P1.5,2 and C:2a:P1.5 isolates.
Despite the widespread acceptance of the PFGE method (4, 10), there is an apparent lack of correlation between an isolate's DNA fingerprint and its antigenic profile. This serves to illustrate a potential limitation of PFGE in the analysis of N. meningitidis strains for molecular epidemiology studies of invasive meningococcal disease. Nevertheless, for localized outbreak analysis, PFGE is still a very useful tool to identify strains linked to a common source (5, 6). In summary, a number of typing tools, including both phenotypic and genotypic methods, should be used in combination with carefully documented epidemiological information for surveillance and analysis of meningococcal disease.

ACKNOWLEDGMENTS
We thank the directors and staff of Provincial Public Health
Laboratories for providing strains for this study. We thank
Averil Henderson and Jan Stoltz for the serotyping and PFGE
data and the DNA core facility at the Public Health Agency of
Canada's National Microbiology Laboratory for DNA sequencing
work.
This publication made use of the Neisseria Multi Locus Sequence Typing website developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union.

FOOTNOTES

Published ahead of print on 9 May 2007.


REFERENCES
1 - Ashton, F. E., J. A. Ryan, A. Borczyk, D. A. Caugant, L. Mancino, and D. Huang. 1991. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J. Clin. Microbiol. 29:2489-2493.[Abstract/Free Full Text]
2 - Law, D. K., A. M. Henderson, and R. S. W. Tsang. 2004. DNA sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens. J. Clin. Microbiol. 42:2718-2723.[Abstract/Free Full Text]
3 - Maiden, M. C. J., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and R. G. Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA 95:3140-3145.[Abstract/Free Full Text]
4 - Patrick, D. M., S. Champagne, S. H. Goh, G. Arsenault, E. Thomas, C. Shaw, T. Rahim, F. Taha, M. Bigham, V. Dubenko, D. Skowronski, and R. C. Brunham. 2003. Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin. Infect. Dis. 37:1183-1188.[CrossRef][Medline]
5 - Popovic, T., S. Schmink, N. A. Rosenstein, G. W. Ajello, M. W. Reeves, B. Plikaytis, S. B. Hunter, E. M. Ribot, D. Boxrud, M. L. Tondella, C. Kim, C. Noble, E. Mothershed, J. Besser, and B. A. Perkins. 2001. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J. Clin. Microbiol. 39:75-85.[Abstract/Free Full Text]
6 - Tsang, R. S. W., L. Kiefer, D. K. S. Law, J. Stoltz, R. Shahin, S. Brown, and F. Jamieson. 2003. Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men. J. Clin. Microbiol. 41:4411-4414.[Abstract/Free Full Text]
7 - Tsang, R. S. W., C. M. Tsai, P. Zhu, L. Ringuette, M. Lorange, and D. K. S. Law. 2004. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada. J. Clin. Microbiol. 42:1460-1465.[Abstract/Free Full Text]
8 - Tsang, R. S. W., D. K. S. Law, A. M. Henderson, M. L. Blake, and J. Stoltz. 2006. Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis. J. Infect. Dis. 194:1791-1792.[CrossRef][Medline]
9 - Tyler, S., and R. Tsang. 2004. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15. Can. J. Microbiol. 50:433-443.[CrossRef][Medline]
10 - Tyrrell, G. J., L. Chui, M. Johnson, N. Chang, R. P. Rennie, J. A. Talbot, and The Edmonton Meningococcal Study Group. 2002. Outbreak of Neisseria meningitidis in Edmonton, Alberta, Canada. Emerg. Infect. Dis. 8:519-521.[Medline]
11 - Vogel, U., H. Claus, M. Frosch, and D. A. Caugant. 2000. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J. Clin. Microbiol. 38:941-942.[Free Full Text]
| | | | | |
Marissa L. Cameron
Raymond S. W. Tsang*
Vaccine Preventable Bacterial Diseases National Microbiology Laboratory Public Health Agency of Canada Winnipeg, Manitoba, Canada R3E 3R2
|
| | | | | |
* Phone: (204) 789-6020, Fax: (204) 789-2018, E-mail: Raymond_Tsang{at}phac-aspc.gc.ca |
Journal of Clinical Microbiology, July 2007, p. 2351-2352, Vol. 45, No. 7
0095-1137/07/$08.00+0 doi:10.1128/JCM.00908-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.